229
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial

, ORCID Icon, , , , & show all
Pages 661-665 | Received 06 Apr 2023, Accepted 14 Jun 2023, Published online: 24 Jun 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.